Skip to main content
Log in

Rheumatic Fever and Post-Group A Streptococcal Arthritis in Children

  • Pediatric Infectious Diseases (I Brook, Section Editor)
  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

There are several diseases associated with group A beta hemolytic streptococcal infection; the two most common are acute rheumatic fever (ARF) and poststreptococcal reactive arthritis (PsRA). Epidemiological and clinical data for both diseases are described, as well as current recommendations for treatment and prevention. There is an ongoing debate as to whether these two are different diseases or are parts of the spectrum of the same disease. There are some reports of carditis developing after PsRA, suggesting that PsRA may be part of the spectrum of ARF. However, since there are substantial clinical, immunological, and genetic differences between PsRA and ARF, we believe PsRA to be a distinct entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3(1):67–84. This paper brings to attention the fact that acute rheumatic fever is still a considerable problem in pediatrics, more so in developing countries, but not only in them.

    PubMed  Google Scholar 

  2. Tibazarwa KB, Volmink JA, Mayosi BM. The incidence of acute rheumatic fever in the world: a systematic review of population based studies. Heart. 2008;94:1534–40.

    Article  PubMed  CAS  Google Scholar 

  3. Wolfe R. Incidence of acute rheumatic fever; a persistent dilemma. Pediatrics. 2000;105:1375.

    Article  PubMed  CAS  Google Scholar 

  4. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. JAMA. 1992;268(15):2069–73

    Google Scholar 

  5. Beg A, Sadiq M. Subclinical valvulitis in children with acute rheumatic fever. Pediatr Cardiol. 2008;29:619–23.

    Article  PubMed  Google Scholar 

  6. Ferrieri P, for the Jones Criteria Working Group. Proceedings of the Jones criteria workshop. Circulation. 2002;106:2521–3.

    Article  PubMed  Google Scholar 

  7. Guilherme L, Ramasawmy R, Kalil J. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol. 2007;66:199–207.

    Article  PubMed  CAS  Google Scholar 

  8. Olmez U, Turgay M, Ozenirler S, et al. Association of HLA class I and class II antigens with rheumatic fever in a Turkish population. Scand J Rheumatol. 1993;22:49–52.

    Article  PubMed  CAS  Google Scholar 

  9. Khanna AK, Gibofsky A, et al. Presence of a non-HLA B cell antigen in rheumatic fever patients and their families as defined by a monoclonal antibody. J Clin Invest. 1989;8:1710–6.

    Article  Google Scholar 

  10. Harel L, Zeharia A, Kodman Y, Straussberg R, Zabriskie JB, Amir J. Presence of the d8/17 B-cell marker in children with rheumatic fever in Israel. Clin Genet. 2002;61:293–8.

    Article  PubMed  CAS  Google Scholar 

  11. Kaplan MH, Meyeserian M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet. 1962;279:706–10.

    Article  Google Scholar 

  12. Kaplan MH, Frengley JD. Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomy and postinfarction syndromes and cardiomyopathies. Am J Cardiol. 1969;24:459–73.

    Article  PubMed  CAS  Google Scholar 

  13. Singer HS, Loiselle CR, Lee O, Garvey MA, Grus FH. Anti-basal ganglia antibody abnormalities in Sydenham chorea. J Neuroimmunol. 2003;136:154–61.

    Article  PubMed  CAS  Google Scholar 

  14. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914–20.

    Article  PubMed  CAS  Google Scholar 

  15. Heye N, Jergas M, Hötzinger H, Farahati J, Pöhlau D, Przuntek H. Sydenham chorea: clinical, EEG, MRI and SPECT findings in the early stage of the disease. J Neurol. 1993;240:121–3.

    Article  PubMed  CAS  Google Scholar 

  16. Faustino PC, Terreri MT, da Rocha AJ, Zappitelli MC, Lederman HM, Hilário MO. Clinical, laboratory, psychiatric and magnetic resonance findings in patients with Sydenham chorea. Neuroradiology. 2003;45:456–62.

    Article  PubMed  Google Scholar 

  17. Hashkes PJ, Tauber T, Someh E, et al. Naproxen as an alternative to Aspirin for the treatment of Arthritis of Rheumatic fever: a randomized trial. J Pediatr. 2003;143(3):399–401.

    Article  PubMed  CAS  Google Scholar 

  18. Carapetis JR, Brown A, Wilson NJ, Edwards KN. An Australian guideline for rheumatic fever and rheumatic heart disease: an abridged outline. Med J Aust. 2007;186:581–6.

    PubMed  Google Scholar 

  19. Barash J, Margalith D, Matitiau A. Corticosteroid treatment in patients with Sydenham’s chorea. Pediatr Neurol. 2005;32(3):205–7.

    Article  PubMed  Google Scholar 

  20. Paz JA, Silva CA, Marques-Dias MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol. 2006;34:264–9.

    Article  PubMed  Google Scholar 

  21. Daoud AS, Zaki M, Shakir R, al-Saleh Q. Effectiveness of sodium valproate in the treatment of Sydenham’s chorea. Neurology. 1990;40970:1140–1.

    Article  Google Scholar 

  22. Harel I, Zecharia A, Straussberg R, et al. Successful treatment of rheumatic chorea with carbamazepine. Pediatr Neurol. 2000;23(2):147–51.

    Article  PubMed  CAS  Google Scholar 

  23. •• Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):1541–51. A very important paper dealing with most recent recommendations for preventing ARF.

    Article  PubMed  CAS  Google Scholar 

  24. Crea MA, Mortimer Jr EA. The nature of scarlatinal arthritis. Pediatrics. 1959;23(5):879–84.

    PubMed  CAS  Google Scholar 

  25. De Cunto CL, Giannini EH, Fink CW, Brewer EJ, Person DA. Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J. 1988;7(10):683–6.

    Article  PubMed  Google Scholar 

  26. Jansen TL, Janssen M, de Jong AJ, Jeurissen ME. Post-streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever. J Intern Med. 1999;245(3):261–7.

    Article  PubMed  CAS  Google Scholar 

  27. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxford). 2004;43(8):949–54.

    Article  CAS  Google Scholar 

  28. Simonini G, Taddio A, Cimaz R. No evidence yet to change American Heart Association recommendations for poststreptococcal reactive arthritis: comment on the article by van Bemmel et al. Arthritis Rheum. 2009;60(11):3516–8.

    Article  PubMed  Google Scholar 

  29. Ayoub EM, Ahmed S. Update on complications of group A streptococcal infections. Curr Probl Pediatr. 1997;27(3):90–101.

    PubMed  CAS  Google Scholar 

  30. •• Barash J, Mashiach E, Navon-Elkan P, Berkun Y, Harel L, Tauber T. et al. Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever. J Pediatr. 2008;153(5):696–9. This paper shows very clearly that ARF and PsRA are two different entities and offers a mathematical formula to differentiate ARF and PsRA.

  31. Moorthy LN, Gaur S, Peterson MG, Landa YF, Tandon M, Lehman TJ. Poststreptococcal reactive arthritis in children: a retrospective study. Clin Pediatr. 2009;48(2):174–82.

    Article  Google Scholar 

  32. Schaffer FM, Agarwal R, Helm J, Gingell RL, Roland JM, O'Neil KM. Poststreptococcal reactive arthritis and silent carditis: a case report and review of the literature. Pediatrics. 1994;93(5):837–9.

    PubMed  CAS  Google Scholar 

  33. van Bemmel JM, Delgado V, Holman ER, Allaart CF, Huizinga TW, Bax JJ, et al. No increased risk of valvular heart disease in adult poststreptococcal reactive arthritis. Arthritis Rheum. 2009;60(4):987–93.

    Article  PubMed  Google Scholar 

  34. Harel L, Mukamel M, Zeharia A, Kodman Y, Prais D, Uziel Y, et al. Presence of D8/17 B-cell marker in patients with poststreptococcal reactive arthritis. Rheumatol Int. 2007;27(8):695–8.

    Article  PubMed  Google Scholar 

  35. Kaplan EL, Rothermel CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics. 1998;101:86–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Judith Barash.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barash, J. Rheumatic Fever and Post-Group A Streptococcal Arthritis in Children. Curr Infect Dis Rep 15, 263–268 (2013). https://doi.org/10.1007/s11908-013-0335-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-013-0335-3

Keywords

Navigation